![Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study | The Egyptian Heart Journal | Full Text Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study | The Egyptian Heart Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43044-020-00045-5/MediaObjects/43044_2020_45_Fig1_HTML.png)
Once versus twice daily antihypertensive medications for the control of nocturnal blood pressure: a comparative study | The Egyptian Heart Journal | Full Text
![LowDose Meds Promising for Patients with High Blood Pressure | CardioSmart – American College of Cardiology LowDose Meds Promising for Patients with High Blood Pressure | CardioSmart – American College of Cardiology](https://www.cardiosmart.org/images/default-source/news-article-images/133635539.jpg?sfvrsn=242d333d_2)
LowDose Meds Promising for Patients with High Blood Pressure | CardioSmart – American College of Cardiology
![Two types of blood pressure meds prevent heart events equally, but side effects differ | American Heart Association Two types of blood pressure meds prevent heart events equally, but side effects differ | American Heart Association](https://s3.amazonaws.com/cms.ipressroom.com/67/files/201710/5a09a9382cfac206544f5421_Blood+Pressure+Chart+1200x630/Blood+Pressure+Chart+1200x630_thmb.jpg)
Two types of blood pressure meds prevent heart events equally, but side effects differ | American Heart Association
![Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial - Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -](https://www.thelancet.com/cms/attachment/43c1acda-e109-481a-b162-60e3f745c2eb/gr1.gif)
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -
![High blood pressure symptoms: Taking a smaller dose of medication could reduce side effect | Express.co.uk High blood pressure symptoms: Taking a smaller dose of medication could reduce side effect | Express.co.uk](https://cdn.images.express.co.uk/img/dynamic/11/590x/Blood-pressure-813832.jpg)
High blood pressure symptoms: Taking a smaller dose of medication could reduce side effect | Express.co.uk
![Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial - Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -](https://www.thelancet.com/cms/attachment/542e7cef-e60c-4235-b1a9-e1f8a67e1b20/gr2_lrg.jpg)
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -
![Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | The BMJ Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | The BMJ](https://www.bmj.com/content/bmj/338/bmj.b1665/F5.large.jpg)